Board Meeting6 Aug 2026, 02:49 pm
Cohance Lifesciences Board Approves Q1 FY27 Unaudited Results
AI Summary
Cohance Lifesciences Ltd announced that its Board of Directors, in a meeting held on August 5, 2026, approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The board also approved the reorganization at Sapala Organics Private Limited, a subsidiary, and the convening of the 8th Annual General Meeting on September 17, 2026. The meeting commenced at 3:30 pm IST and concluded at 5:25 pm IST.
Key Highlights
- Board approved unaudited standalone and consolidated financial results for Q1 FY27.
- Reorganization at subsidiary Sapala Organics Private Limited approved.
- 8th Annual General Meeting scheduled for September 17, 2026.
- Financial results and investor presentation were disclosed.
- Limited Review Reports from auditors were also submitted.
Price Impact
More from SUVENPHAR